Jeffrey W. Albers serves as Executive at Blueprint Medicines Corp, where they oversee executive responsibilities. Since joining the company, Jeffrey W. Albers has executed 213 insider transactions totaling $58.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 8, 2025 involved exercising options for 5,000 shares valued at $70.9K.
Jeffrey W. Albers currently holds 5,000 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey W. Albers has been a net seller of BPMC stock. They have purchased $0 and sold $58.2M worth of shares.
Jeffrey W. Albers's most recent insider trade was on Dec 8, 2025, when they sold 5,000 shares at $14.18 per share.
Get notified when new Form 4 filings are submitted
| $89.32 |
| Discretionary |
| Dec 8, 2025 | KYMR | $203.4K | Sale | 2,252 | $90.30 | Discretionary |
| Oct 13, 2025 | KYMR | $295.9K | Sale | 5,000 | $59.19 | Discretionary |
| Oct 13, 2025 | KYMR | $51.7K | Option Exercise | 5,000 | $10.34 | Discretionary |
| Sep 9, 2024 | BPMC | $360.5K | Option Exercise | 10,000 | $36.05 | Planned |
| Sep 9, 2024 | BPMC | $1.0M | Sale | 11,968 | $85.86 | Planned |
| Sep 9, 2024 | BPMC | $658.3K | Sale | 7,734 | $85.12 | Planned |
| Aug 26, 2024 | KYMR | $51.7K | Option Exercise | 5,000 | $10.34 | Planned |
| Aug 26, 2024 | KYMR | $245.5K | Sale | 5,000 | $49.10 | Planned |
| Jun 12, 2024 | BPMC | $0 | Award | 2,242 | $N/A | Discretionary |
| Mar 20, 2024 | BPMC | $150.1K | Option Exercise | 10,000 | $15.01 | Planned |
| Mar 20, 2024 | BPMC | $28.2K | Option Exercise | 15,073 | $1.87 | Planned |
| Mar 20, 2024 | BPMC | $121.8K | Sale | 1,367 | $89.12 | Planned |
| Mar 20, 2024 | BPMC | $556.9K | Sale | 6,285 | $88.60 | Planned |
| Mar 20, 2024 | BPMC | $736.5K | Sale | 8,440 | $87.26 | Planned |
| Mar 20, 2024 | BPMC | $540.5K | Sale | 6,251 | $86.46 | Planned |
| Mar 20, 2024 | BPMC | $232.7K | Sale | 2,730 | $85.22 | Planned |
| Mar 7, 2024 | BPMC | $1.0M | Sale | 11,033 | $90.69 | Discretionary |
| Feb 21, 2024 | KYMR | $171.2K | Sale | 4,385 | $39.05 | Planned |
| Feb 21, 2024 | KYMR | $45.3K | Option Exercise | 4,385 | $10.34 | Planned |
| Feb 20, 2024 | KYMR | $6.4K | Option Exercise | 615 | $10.34 | Planned |
| Feb 20, 2024 | KYMR | $24.0K | Sale | 615 | $39.07 | Planned |
| Jan 25, 2024 | BPMC | $150.1K | Option Exercise | 10,000 | $15.01 | Planned |
| Jan 25, 2024 | BPMC | $493.9K | Sale | 6,086 | $81.16 | Planned |
| Jan 25, 2024 | BPMC | $889.7K | Sale | 10,890 | $81.70 | Planned |
| Jan 25, 2024 | BPMC | $655.8K | Sale | 7,924 | $82.76 | Planned |
| Jan 25, 2024 | BPMC | $8.4K | Sale | 100 | $83.57 | Planned |
| Jan 25, 2024 | BPMC | $28.1K | Option Exercise | 15,000 | $1.87 | Planned |
| Jan 23, 2024 | KYMR | $103.4K | Option Exercise | 10,000 | $10.34 | Planned |